Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 6 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
FISHER PHARMACEUTICALS from Sint-Pieters-Woluwe, company number BE1016131517, closed financial year 2025 with a result of € 1,617 after tax. For that financial year FISHER PHARMACEUTICALS recorded a gross margin of € 3,481 and equity of € 3,617. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on January 30, 2026.
€ 3,617
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 1,617
Profit after tax over the fiscal year.
€ 26
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 1,617.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 347
Supplier invoices still open on the last day of the fiscal year.
€ 539
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
What happened to FISHER PHARMACEUTICALS?
What happened at FISHER PHARMACEUTICALS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 1,617. Source: NBB ↗
- New establishment in Sint-Pieters-Woluwe. KBO
- Start of the company according to the CBE. KBO
- azam ghadiri became a director. NBB
In short
Paid € 539 in corporate taxes since 2025.
A new publication or filing at FISHER PHARMACEUTICALS? We notify you, reason included.
Follow FISHER PHARMACEUTICALSDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind FISHER PHARMACEUTICALS is azam ghadiri.
Directors
According to the 2025 annual accounts
azam ghadiri
Administrator-manager
since 2024
Establishments
Establishment units
Physical locations of this company
Gebroeders Legrainlaan 76
1150 Sint-Pieters-Woluwe
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 7 companies are registered at this address.
All companies at this address →FISHER
€ 64,073 revenue · 2024
Triangle A.M.P.
€ 473,414 revenue · 2025
DE MALTE A GOZO
€ 35,831 revenue · 2025
Association des copropriétaires de la Résidence sise à Woluwe-Saint -Pierre, avenue des Frères Legrain 76
CHROMWELL
€ 205 gross margin · 2025
+2 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 1016.131.517
- VAT number
- BE 1016.131.517
- Registered office
- Gebroeders Legrainlaan 76, 1150 Sint-Pieters-Woluwe
- Names & denominations
- FISHER PHARMACEUTICALS
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 12 November 2024
- Peppol
- Active · Active since 18 Dec 2025
- Activities · NACE
Niet-gespecialiseerde groothandel
Vervaardiging van overige farmaceutische producten
Groothandel in andere voedingsmiddelen, neg